-
Article
Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma
Follicular Lymphoma International Prognostic Index—FLIPI is an established clinical predictor for outcome in follicular lymphoma. The role of molecular abnormalities in blood and bone marrow of follicular lymp...
-
Article
Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma
The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses in patients with recurrent indolent lymphoma. Thirty-eight patients entered int...
-
Article
CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma
Patients with recurrent or refractory Hodgkin's and non-Hodgkin's lymphoma are increasingly being treated with high-dose therapy and hematopoietic cell transplantation. As minimal disease status at the time of...